XML 55 R42.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Revenue (Disaggregation of Revenue by Geographical Region) (Details) - USD ($) $ in Millions | 3 Months Ended
--- | ---
Mar. 29, 2024 | Mar. 31, 2023
Disaggregation of Revenue [Line Items] |  |
Revenue | $ 5,796 | $ 5,949
Recurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 4,795 | 4,662
Nonrecurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,001 | 1,287
North America |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 2,632 | 2,450
Western Europe |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,324 | 1,431
Other developed markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 303 | 324
High-growth markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,537 | 1,744
Operating segments | Biotechnology |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,524 | 1,864
Operating segments | Biotechnology | Recurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,309 | 1,511
Operating segments | Biotechnology | Nonrecurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 215 | 353
Operating segments | Biotechnology | North America |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 514 | 618
Operating segments | Biotechnology | Western Europe |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 546 | 647
Operating segments | Biotechnology | Other developed markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 79 | 79
Operating segments | Biotechnology | High-growth markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 385 | 520
Operating segments | Life Sciences |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,745 | 1,709
Operating segments | Life Sciences | Recurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,192 | 1,039
Operating segments | Life Sciences | Nonrecurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 553 | 670
Operating segments | Life Sciences | North America |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 781 | 708
Operating segments | Life Sciences | Western Europe |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 372 | 364
Operating segments | Life Sciences | Other developed markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 125 | 128
Operating segments | Life Sciences | High-growth markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 467 | 509
Operating segments | Diagnostics |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 2,527 | 2,376
Operating segments | Diagnostics | Recurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 2,294 | 2,112
Operating segments | Diagnostics | Nonrecurring revenue |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 233 | 264
Operating segments | Diagnostics | North America |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 1,337 | 1,124
Operating segments | Diagnostics | Western Europe |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 406 | 420
Operating segments | Diagnostics | Other developed markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | 99 | 117
Operating segments | Diagnostics | High-growth markets |  |
Disaggregation of Revenue [Line Items] |  |
Revenue | $ 685 | $ 715

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementRecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_NorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_WesternEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_OtherdevelopedmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_HighgrowthmarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_BiotechnologySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_LifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_DiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |